The global blood glucose monitoring devices market size is expected to reach 19.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.6% from 2021 to 2028. The market growth is propelled by the rising diabetes prevalence worldwide and increasing geriatric population. Moreover, rising awareness about diabetes preventive care and new product launches are expected to boost market growth.
Blood
glucose monitoring (BGM) devices are used to measure blood glucose levels in
diabetes patients. These devices help in analyzing glucose level pattern as it
provides continuous and real-time blood sugar reading. It also helps patients
to decide the amount of food intake and dosage of insulin. Furthermore, factors
such as sedentary lifestyle, consumption of junk food and alcohol, smoking, and
surge in the need for safer and faster diagnosis are propelling the market
growth.
Obesity
is also one of the major factors in propelling the prevalence of diabetes.
According to the WHO, over 650 million people were obese in 2016 and this
number is expected to grow further during the forecast period. Additionally,
the market is expected to witness a high growth rate during the forecast period
due to the continuous efforts for diabetes control by government and healthcare
organizations, such as the International Diabetes Federation (IDF). Such
organizations provide the required expertise and support diabetes awareness
campaigns through a network of stakeholders and partners. Moreover, increasing
health care funding is anticipated to propel the market growth.
For more info visit here: https://www.grandviewresearch.com/industry-analysis/blood-glucose-monitoring-bgm-devices-market
Blood Glucose
Monitoring Devices Market Report Highlights
- North America
held the largest market share in 2020 owing to favorable reimbursement
policies, local presence of key players, and supportive government
initiatives
- Based on
product, the self-monitoring devices segment held the largest market share
in 2020 and is expected to grow at a significant pace over the forecast
period. The testing strips segment of self-monitoring devices held the
largest share of more than 40.0% in 2020 and is projected to grow at a
healthy CAGR over the forecast period
- The continuous
blood glucose monitoring devices segment is expected to be the
fastest-growing segment during the forecast period
- By end-use,
the home care segment is expected to grow at a rapid pace during the
forecast period
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment